MX2019006982A - Sistema y metodo para matriz de sensores de corona de proteinas para la deteccion temprana de enfermedades. - Google Patents
Sistema y metodo para matriz de sensores de corona de proteinas para la deteccion temprana de enfermedades.Info
- Publication number
- MX2019006982A MX2019006982A MX2019006982A MX2019006982A MX2019006982A MX 2019006982 A MX2019006982 A MX 2019006982A MX 2019006982 A MX2019006982 A MX 2019006982A MX 2019006982 A MX2019006982 A MX 2019006982A MX 2019006982 A MX2019006982 A MX 2019006982A
- Authority
- MX
- Mexico
- Prior art keywords
- diseases
- sensor array
- early detection
- protein corona
- corona sensor
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 108010020147 Protein Corona Proteins 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 238000003491 array Methods 0.000 abstract 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/5432—Liposomes or microcapsules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/02—Investigating particle size or size distribution
- G01N15/0205—Investigating particle size or size distribution by optical means
- G01N15/0211—Investigating a scatter or diffraction pattern
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/02—Investigating particle size or size distribution
- G01N15/0205—Investigating particle size or size distribution by optical means
- G01N15/0211—Investigating a scatter or diffraction pattern
- G01N2015/0222—Investigating a scatter or diffraction pattern from dynamic light scattering, e.g. photon correlation spectroscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Data Mining & Analysis (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Bioethics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Nanotechnology (AREA)
Abstract
La presente invención proporciona matrices de sensores para detectar biomoléculas y métodos de uso. En algunas modalidades, las matrices de sensores son capaces de determinar un estado de enfermedad en un sujeto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662435409P | 2016-12-16 | 2016-12-16 | |
PCT/US2017/067013 WO2018112460A1 (en) | 2016-12-16 | 2017-12-18 | System and method for protein corona sensor array for early detection of diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019006982A true MX2019006982A (es) | 2019-12-02 |
Family
ID=62559844
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019006982A MX2019006982A (es) | 2016-12-16 | 2017-12-18 | Sistema y metodo para matriz de sensores de corona de proteinas para la deteccion temprana de enfermedades. |
MX2022004293A MX2022004293A (es) | 2016-12-16 | 2019-06-13 | Sistema y metodo para matriz de sensores de corona de proteinas para la deteccion temprana de enfermedades. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022004293A MX2022004293A (es) | 2016-12-16 | 2019-06-13 | Sistema y metodo para matriz de sensores de corona de proteinas para la deteccion temprana de enfermedades. |
Country Status (14)
Country | Link |
---|---|
US (3) | US10866242B2 (es) |
EP (2) | EP4056263A1 (es) |
JP (3) | JP7069170B2 (es) |
CN (5) | CN116908452A (es) |
AU (2) | AU2017375496B2 (es) |
CA (1) | CA3046540A1 (es) |
DE (4) | DE202017107858U1 (es) |
DK (1) | DK3554681T3 (es) |
ES (1) | ES2914787T3 (es) |
GB (1) | GB2561940A (es) |
MX (2) | MX2019006982A (es) |
PL (1) | PL3554681T3 (es) |
PT (1) | PT3554681T (es) |
WO (1) | WO2018112460A1 (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201615128D0 (en) * | 2016-09-06 | 2016-10-19 | Univ Manchester | Methods |
CA3046540A1 (en) | 2016-12-16 | 2018-06-21 | The Brigham And Women's Hospital, Inc. | System and method for protein corona sensor array for early detection of diseases |
US20210072255A1 (en) | 2016-12-16 | 2021-03-11 | The Brigham And Women's Hospital, Inc. | System and method for protein corona sensor array for early detection of diseases |
EP3716838A4 (en) * | 2017-11-27 | 2021-08-11 | Retispec Inc. | RAMAN EYE IMAGER, GUIDED BY HYPERSPECTRAL IMAGE, FOR PATHOLOGIES OF ALZHEIMER'S MORBUS |
CN108760700A (zh) * | 2018-05-29 | 2018-11-06 | 云南健牛生物科技有限公司 | 一种荧光金纳米簇的制备及用于四环素及铜荧光探针 |
SG11202104619WA (en) | 2018-11-07 | 2021-06-29 | Seer Inc | Compositions, methods and systems for protein corona analysis and uses thereof |
CN109212217B (zh) * | 2018-11-07 | 2021-09-10 | 李玉民 | 基于amy1a蛋白胃癌检测试剂盒及其使用方法 |
CN109599177B (zh) * | 2018-11-27 | 2023-04-11 | 华侨大学 | 一种基于病历的深度学习预测医疗轨迹的方法 |
CN109734792B (zh) * | 2019-01-17 | 2022-05-24 | 武汉明德生物科技股份有限公司 | 人cntn1抗原、人cntn1抗体检测试剂盒及其制备方法与应用 |
GB201903054D0 (en) * | 2019-03-07 | 2019-04-24 | Univ Bristol | Sensor |
KR20220011618A (ko) * | 2019-03-26 | 2022-01-28 | 시어 인코퍼레이티드 | 생체 유체로부터의 단백질 코로나 분석을 위한 조성물, 방법 및 시스템 및 그것들의 용도 |
CN110385427B (zh) * | 2019-07-31 | 2021-10-19 | 东南大学 | 一种水溶性纳米粒子及其制备方法和应用 |
IL290257B2 (en) * | 2019-08-05 | 2023-11-01 | Seer Inc | Systems and methods for sample preparation, data generation and corona protein analysis |
CN112578125B (zh) * | 2019-09-27 | 2022-10-25 | 成都中医药大学 | 检测粪钙卫蛋白含量的试剂在制备卵巢病变筛查试剂盒中的用途 |
WO2021087407A1 (en) * | 2019-11-02 | 2021-05-06 | Seer, Inc. | Systems for protein corona analysis |
CN111292801A (zh) * | 2020-01-21 | 2020-06-16 | 西湖大学 | 蛋白质质谱结合深度学习评估甲状腺结节的方法 |
AU2021213150A1 (en) * | 2020-01-30 | 2022-08-04 | Prognomiq Inc | Lung biomarkers and methods of use thereof |
DE102020202262A1 (de) | 2020-02-21 | 2021-08-26 | Robert Bosch Gesellschaft mit beschränkter Haftung | Verfahren zur Herstellung einer nanoskaligen Kanalstruktur |
US20210333222A1 (en) * | 2020-04-24 | 2021-10-28 | Nokomis, Inc | Rf rapid diagnostics of infection and contamination |
US20210350897A1 (en) * | 2020-05-06 | 2021-11-11 | Janssen Pharmaceuticals, Inc. | Aggregating and analyzing drug administration data |
WO2021243285A1 (en) * | 2020-05-29 | 2021-12-02 | Seer, Inc. | Systems and methods for rapid identification of proteins |
GB202008287D0 (en) * | 2020-06-02 | 2020-07-15 | Kostarelos Kostas | Methods of determining cancer |
WO2022020272A1 (en) * | 2020-07-20 | 2022-01-27 | Seer, Inc. | Particles and methods of assaying |
GB202012434D0 (en) * | 2020-08-10 | 2020-09-23 | Univ Manchester | Multiomic analysis of nanoparticle-coronas |
GB202012433D0 (en) * | 2020-08-10 | 2020-09-23 | Univ Manchester | Nanoparticle-enabled analysis of cell-free nucleic acid in complex biological fluids |
CN112034182A (zh) * | 2020-09-01 | 2020-12-04 | 复旦大学附属中山医院 | 一种结肠癌转移预测方法和系统 |
US20220260559A1 (en) * | 2020-11-04 | 2022-08-18 | Seer, Inc. | Biomarkers for diagnosing alzheimer's disease |
US11250723B1 (en) * | 2020-11-04 | 2022-02-15 | King Abdulaziz University | Visuospatial disorders detection in dementia using a computer-generated environment based on voting approach of machine learning algorithms |
IT202000031139A1 (it) * | 2020-12-16 | 2022-06-16 | Univ Degli Studi Roma La Sapienza | Test sierologico per coadiuvare la diagnosi e il monitoraggio del glioblastoma multiforme |
CN112730692B (zh) * | 2021-01-08 | 2022-11-29 | 首都医科大学附属北京朝阳医院 | 用于预测胎膜早破的生物标记物和方法 |
AU2022209365A1 (en) | 2021-01-21 | 2023-07-20 | Nautilus Subsidiary, Inc. | Systems and methods for biomolecule preparation |
GB202102399D0 (en) * | 2021-02-19 | 2021-04-07 | Univ Manchester | Methods of determining alzheimer's disease |
CN112951321B (zh) * | 2021-03-01 | 2023-10-24 | 湖南大学 | 一种基于张量分解的miRNA-疾病关联预测方法及系统 |
EP4056271A1 (en) * | 2021-03-10 | 2022-09-14 | Cline Scientific AB | Quantification of cell migration and metastatic potential of tumor cells |
CN113409335B (zh) * | 2021-06-22 | 2023-04-07 | 西安邮电大学 | 基于强弱联合半监督直觉模糊聚类的图像分割方法 |
US11735303B2 (en) * | 2021-06-22 | 2023-08-22 | David Haase | Apparatus and method for determining a composition of a replacement therapy treatment |
CN113470739B (zh) * | 2021-07-03 | 2023-04-18 | 中国科学院新疆理化技术研究所 | 一种基于混合隶属度随机块模型的蛋白质相互作用预测方法和系统 |
AU2022341187A1 (en) | 2021-09-13 | 2024-03-21 | PrognomIQ, Inc. | Enhanced detection and quantitation of biomolecules |
CN114019042B (zh) * | 2021-10-29 | 2023-06-20 | 浙江工商大学 | 基于石墨烯的黄颡鱼蛋白酶抑制剂含量测定方法及装置 |
WO2023141580A2 (en) * | 2022-01-20 | 2023-07-27 | Seer, Inc. | Particles and methods of assaying |
CN117593306B (zh) * | 2024-01-19 | 2024-05-03 | 数据空间研究院 | 一种功能磁共振大脑皮层的分区方法及系统 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US6361944B1 (en) | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
AU1725200A (en) | 1998-11-16 | 2000-06-05 | California Institute Of Technology | Simultaneous determination of equilibrium and kinetic properties |
US6969615B2 (en) | 1999-07-26 | 2005-11-29 | 20/20 Genesystems, Inc. | Methods, devices, arrays and kits for detecting and analyzing biomolecules |
US6780602B2 (en) | 2001-11-01 | 2004-08-24 | Microbiosystems, Limited Partnership | Taxonomic identification of pathogenic microorganisms and their toxic proteins |
US7375234B2 (en) | 2002-05-30 | 2008-05-20 | The Scripps Research Institute | Copper-catalysed ligation of azides and acetylenes |
CN1832763A (zh) * | 2003-06-05 | 2006-09-13 | 森特利昂公司 | 编码纤维母细胞生长因子的质粒用于治疗与高胆固醇血症或糖尿病相关的血管生成缺陷 |
DE102004051785B4 (de) | 2004-10-25 | 2008-04-24 | Bruker Daltonik Gmbh | Proteinprofile mit Luft-MALDI |
US9002652B1 (en) | 2005-01-27 | 2015-04-07 | Institute For Systems Biology | Methods for identifying and using organ-specific proteins in blood |
US20070224644A1 (en) * | 2006-01-27 | 2007-09-27 | Liotta Lance A | Ocular fluid markers |
EP2209893B1 (en) | 2007-10-12 | 2013-11-20 | Pronota NV | Use of aptamers in proteomics |
US8021891B2 (en) | 2007-11-28 | 2011-09-20 | University Of Massachusetts | Methods and compositions for protein detection using nanoparticle-fluorescent polymer complexes |
KR101039629B1 (ko) * | 2008-05-22 | 2011-06-08 | 성균관대학교산학협력단 | 생체물질의 검출방법, 생체물질 검출용 칩의 제조방법 및생물질 검출용 칩 |
US20120046184A1 (en) * | 2009-02-26 | 2012-02-23 | University College Dublin, National University Of Ireland, Dublin | method for the selective concentration of a specific low abundance biomolecule |
US20120190574A1 (en) | 2009-06-19 | 2012-07-26 | The Arizona Board of Regents, A body Corporate of the State of Arizona for and on behalf of Arizona | Compound Arrays for Sample Profiling |
CA2787201A1 (en) | 2010-01-14 | 2011-07-21 | University Of Central Florida Research Foundation, Inc. | Methods for biomolecule and biomolecule complex (bmc) detection and analysis and the use of such for research and medical diagnosis |
CN102906275A (zh) | 2010-02-10 | 2013-01-30 | 加利福尼亚大学董事会 | 肺癌检测的唾液生物标记 |
US9329176B2 (en) | 2010-11-18 | 2016-05-03 | Academia Sinica | Glycopeptide-functionalized nanoparticles arrays for capturing and detecting biomolecules |
WO2012106385A2 (en) * | 2011-01-31 | 2012-08-09 | Apprise Bio, Inc. | Methods of identifying multiple epitopes in cells |
GB201103726D0 (en) | 2011-03-04 | 2011-04-20 | Immunovia Ab | Method, array and use thereof |
EP2718721A4 (en) * | 2011-06-07 | 2014-10-01 | Caris Life Sciences Luxembourg Holdings S A R L | CIRCULATING BIOMARKERS FOR CANCER |
US20130058923A1 (en) * | 2011-08-03 | 2013-03-07 | Qun Huo | Biomolecular interactions and interaction products as biomarkers for detection, diagnosis, prognosis and predicting therapeutic responses of human diseases |
CN103874770A (zh) * | 2011-08-08 | 2014-06-18 | 卡里斯生命科学卢森堡控股有限责任公司 | 生物标志物组合物和方法 |
BR112014004014A2 (pt) * | 2011-08-23 | 2020-10-27 | President And Fellows Of Harvard College | partículas de peptídeos e seus usos |
US10900975B2 (en) | 2015-05-12 | 2021-01-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Systems and methods of epitope binning and antibody profiling |
WO2017091631A1 (en) | 2015-11-23 | 2017-06-01 | Massachusetts Institute Of Technology | Protein corona phase molecular recognition |
GB201615128D0 (en) | 2016-09-06 | 2016-10-19 | Univ Manchester | Methods |
CA3046540A1 (en) | 2016-12-16 | 2018-06-21 | The Brigham And Women's Hospital, Inc. | System and method for protein corona sensor array for early detection of diseases |
-
2017
- 2017-12-18 CA CA3046540A patent/CA3046540A1/en active Pending
- 2017-12-18 DE DE202017107858.2U patent/DE202017107858U1/de active Active
- 2017-12-18 JP JP2019532058A patent/JP7069170B2/ja active Active
- 2017-12-18 DE DE202017007364.1U patent/DE202017007364U1/de active Active
- 2017-12-18 EP EP21216039.4A patent/EP4056263A1/en active Pending
- 2017-12-18 GB GB1721605.2A patent/GB2561940A/en not_active Withdrawn
- 2017-12-18 CN CN202310854243.0A patent/CN116908452A/zh active Pending
- 2017-12-18 DE DE202017007366.8U patent/DE202017007366U1/de active Active
- 2017-12-18 DK DK17881767.2T patent/DK3554681T3/da active
- 2017-12-18 DE DE202017007363.3U patent/DE202017007363U1/de active Active
- 2017-12-18 WO PCT/US2017/067013 patent/WO2018112460A1/en active Application Filing
- 2017-12-18 PT PT178817672T patent/PT3554681T/pt unknown
- 2017-12-18 ES ES17881767T patent/ES2914787T3/es active Active
- 2017-12-18 MX MX2019006982A patent/MX2019006982A/es unknown
- 2017-12-18 PL PL17881767T patent/PL3554681T3/pl unknown
- 2017-12-18 CN CN202111607429.3A patent/CN114441747B/zh active Active
- 2017-12-18 AU AU2017375496A patent/AU2017375496B2/en active Active
- 2017-12-18 EP EP17881767.2A patent/EP3554681B1/en active Active
- 2017-12-18 CN CN202111607530.9A patent/CN114441765A/zh active Pending
- 2017-12-18 CN CN201780011881.9A patent/CN109070040B/zh active Active
- 2017-12-18 CN CN202310855325.7A patent/CN116908453A/zh active Pending
-
2018
- 2018-01-26 US US15/880,627 patent/US10866242B2/en active Active
-
2019
- 2019-06-13 MX MX2022004293A patent/MX2022004293A/es unknown
-
2020
- 2020-11-09 US US17/092,736 patent/US20210311064A1/en not_active Abandoned
-
2021
- 2021-03-29 US US17/215,978 patent/US20210293801A1/en not_active Abandoned
-
2022
- 2022-03-03 JP JP2022032563A patent/JP7307220B2/ja active Active
-
2023
- 2023-05-08 AU AU2023202853A patent/AU2023202853A1/en active Pending
- 2023-06-28 JP JP2023105611A patent/JP2023123715A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022004293A (es) | Sistema y metodo para matriz de sensores de corona de proteinas para la deteccion temprana de enfermedades. | |
IL289907A (en) | Methods and systems for identification and analysis of tested material | |
WO2014165022A3 (en) | Optical tomography sensor and related apparatus and methods | |
WO2014144548A3 (en) | Systems and methods for mobile device analysis of nucleic acids and proteins | |
PH12017501967A1 (en) | Maize plant dbn9936 and method for use in detecting nucleic acid sequence thereof | |
SA518400078B1 (ar) | مصفوفة مولد ضد | |
MX2016013261A (es) | Metodo para la cuantificacion de huevos de parasitos en las heces. | |
SG11202109764VA (en) | Methods, devices, and systems for analyte detection and analysis | |
EP3767335A4 (en) | DISTANCE MEASUREMENT METHOD AND APPARATUS, DISTANCE MEASUREMENT SENSOR AND DISTANCE MEASUREMENT DETECTION NETWORK | |
WO2014207049A3 (de) | Verfahren zur bestimmung von proteinaggregaten unter verwendung von oberflächen-fida | |
EP3714242A4 (en) | NON-CONTACT HUMIDITY DETECTION SYSTEM AND METHOD BY THERMAL CAPTURE | |
EP3878359A4 (en) | BIOLOGICAL ELECTRODE, BIOLOGICAL SENSOR AND BIOLOGICAL SIGNAL MEASUREMENT SYSTEM | |
SG10201701417TA (en) | Systems And Methods For Identifying Body Joint Locations Based On Sensor Data Analysis | |
EP3628069A4 (en) | SYSTEM AND METHOD FOR MEASUREMENT OF ANALYTES IN GMR-BASED DETECTION OF BIOMARKERS | |
AU2017248682A1 (en) | Method for detecting and/or characterising tumour cells and associated apparatus | |
PH12019501837A1 (en) | Radiolabeled anti-lag3 antibodies for immuno-pet imaging | |
IT201600073964A1 (it) | Nanointerruttore basato su nucleotidi e metodi per la rilevazione di anticorpi e altri analiti | |
GB201908596D0 (en) | Sensor system, sensing element and methods | |
SG10201806729VA (en) | Novel assay to detect human periostin | |
EP3847459A4 (en) | SYSTEMS, SENSORS AND METHODS FOR DETERMINING A CONCENTRATION OF AN ANALYTE | |
WO2016205828A3 (en) | Role of citrullination in diagnosing diseases | |
EP3611505A4 (en) | ACCURATE, RAPID AND CONVENIENT ONE-STEP DISEASE DIAGNOSIS PROCESS USING THE PRINCIPLE OF SELF-AMPLIFICATION OF A DETECTION SIGNAL | |
EP3324848A4 (en) | SENSOR, SENSOR CUSHION AND SENSOR ARRAY FOR DETECTING INFRASONIC ACOUSTIC SIGNALS | |
WO2019199797A8 (en) | Device and method for detecting disease states associated with lipopigments | |
EP3490451A4 (en) | PET BLOOD TESTER, PET BLOOD TEST SYSTEM AND PET BLOOD TEST METHOD THEREFOR |